Palomino Laboratories (PALX) Other Accumulated Expenses (2022 - 2025)

Palomino Laboratories has disclosed Other Accumulated Expenses across 4 years of filings, most recently posting $3140.0 for Q3 2025.

• Other Accumulated Expenses for Q3 2025 came in at $3140.0, down 92.98% year-over-year; the trailing twelve-month figure through Sep 2025 was $3140.0 (down 92.98% YoY), and the FY2024 annual result was $3140.0, down 90.19% from the prior year.
• Other Accumulated Expenses came in at $3140.0 for Q3 2025 at Palomino Laboratories, down from $6500.0 in the prior quarter.
• In the past five years, Other Accumulated Expenses ranged from a high of $44750.0 in Q3 2024 to a low of $2250.0 in Q1 2025.
• The 4-year median for Other Accumulated Expenses is $15000.0 (2022), against an average of $20392.2.
• Across the five-year window, Other Accumulated Expenses jumped 113.33% in 2023 and slumped 93.79% in 2025, its largest moves.
• Palomino Laboratories' Other Accumulated Expenses stood at $15000.0 in 2022, then surged by 113.33% to $32000.0 in 2023, then plunged by 90.19% to $3140.0 in 2024, then changed by 0.0% to $3140.0 in 2025.
• The last three Other Accumulated Expenses figures came in at $3140.0 (Q3 2025), $6500.0 (Q2 2025), and $2250.0 (Q1 2025), per Business Quant data.